The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Adipose‐Derived Mesenchymal Stem Cells Exert Antiinflammatory Effects on Chondrocytes and Synoviocytes From Osteoarthritis Patients Through Prostaglandin E2
Abstract
Objective: To examine the effect of different sources of Good Manufacturing Practice clinical grade adipose‐derived mesenchymal stem cells (AD‐MSCs) on inflammatory factors in osteoarthritic (OA) chondrocytes and synoviocytes. Methods: AD‐MSCs from infrapatellar Hoffa fat, subcutaneous (SC) hip fat, and SC abdominal fat were cocultured in Transwells with chondrocytes or synoviocytes. Inflammatory factors (interleukin‐1β [IL‐1β], tumor necrosis factor α, IL‐6, CXCL1/growth‐related oncogene α, CXCL8/IL‐8, CCL2/monocyte chemotactic protein 1, CCL3/macrophage inflammatory protein 1α, and CCL5/RANTES) were evaluated by quantitative reverse transcription–polymerase chain reaction or multiplex bead–based immunoassay. The role of different immunomodulators was analyzed. Results: All the inflammatory factors analyzed were down‐modulated at the messenger RNA or protein level independently by all 3 AD‐MSC sources or by allogeneic AD‐MSCs used in coculture with chondrocytes or synoviocytes. Inflammatory factor down‐modulation was observed only when AD‐MSCs were cocultured with chondrocytes or synoviocytes that produced high levels of inflammatory factors, but no effect was observed in cells that produced low levels of those factors, thus highlighting a dependence of the AD‐MSC effect on existing inflammation. The immunomodulators IL‐10, IL‐1 receptor antagonist, fibroblast growth factor 2, indoleamine 2,3‐dioxygenase 1, and galectin 1 were not involved in AD‐MSC effects, whereas the cyclooxygenase 2 (COX‐2)/prostaglandin E 2 (PGE 2) pathway exerted a role in the mechanism of antiinflammatory AD‐MSC action. Conclusion: The antiinflammatory effects of AD‐MSCs are probably not dependent on AD‐MSC adipose tissue sources and donors but rather on the inflammatory status of OA chondrocytes and synoviocytes. AD‐MSCs seem to be able to sense and respond to the local environment. Even though a combination of different molecules may be involved in AD‐MSC effects, the COX‐2/PGE 2 pathway may play a role, suggesting that AD‐MSCs may be useful for therapies in osteoarticular diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multilineage Cells from Human Adipose Tissue: Implications for Cell-Based Therapies
Zuk, P. A., Zhu, M., Mizuno, H., Huang, J., Futrell, J. W., Katz, A. J., Benhaim, P., Lorenz, H. P., & Hedrick, M. H. (2001) · Tissue Engineering · doi:10.1089/107632701300062859 · Cited by 7,956
Human mesenchymal stem cells modulate B-cell functions
Corcione, A., Benvenuto, F., Ferretti, E., Giunti, D., Cappiello, V., Cazzanti, F., Risso, M., Gualandi, F., Mancardi, G. L., Pistoia, V., et al. (2006) · Blood · doi:10.1182/blood-2005-07-2657 · Cited by 1,767
Mesenchymal Stem/Stromal Cells (MSCs): Role as Guardians of Inflammation
Prockop, D. J., & Youn Oh, J. (2012) · Molecular Therapy · doi:10.1038/mt.2011.211 · Cited by 816 · cited 1×
“It has been reported that in vitro human MSCs require activation, and activating stimuli appear to include proinflammatory cytokines (IL-1 , IFN , TNF ) or interaction with monocytes (11,34).”
BackgroundDuijvestein, M., Vos, A. C. W., Roelofs, H., Wildenberg, M. E., Wendrich, B. B., Verspaget, H. W., Kooy-Winkelaar, E. M. C., Koning, F., Zwaginga, J. J., Fidder, H. H., et al. (2010) · Gut · doi:10.1136/gut.2010.215152 · Cited by 622
Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications
Ghannam, S., Bouffi, C., Djouad, F., Jorgensen, C., & Noël, D. (2010) · Stem Cell Research & Therapy · doi:10.1186/scrt2 · Cited by 507
Self-citationThe immunomodulatory properties of mesenchymal stem cells and their use for immunotherapy
Hoogduijn, M. J., Popp, F., Verbeek, R., Masoodi, M., Nicolaou, A., Baan, C., & Dahlke, M.-H. (2010) · International Immunopharmacology · doi:10.1016/j.intimp.2010.06.019 · Cited by 248
Cited by
Repair and tissue engineering techniques for articular cartilage
Makris, E. A., Gomoll, A. H., Malizos, K. N., Hu, J. C., & Athanasiou, K. A. (2015) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2014.157 · Cited by 1,245
Cosenza, S., Ruiz, M., Toupet, K., Jorgensen, C., & Noël, D. (2017) · Scientific Reports · doi:10.1038/s41598-017-15376-8 · Cited by 649
Self-citationHofer, H. R., & Tuan, R. S. (2016) · Stem Cell Research & Therapy · doi:10.1186/s13287-016-0394-0 · Cited by 360
Exosomes: roles and therapeutic potential in osteoarthritis
Ni, Z., Zhou, S., Li, S., Kuang, L., Chen, H., Luo, X., Ouyang, J., He, M., Du, X., & Chen, L. (2020) · Bone Research · doi:10.1038/s41413-020-0100-9 · Cited by 288
Small extracellular vesicles from human adipose‐derived stem cells attenuate cartilage degeneration
Woo, C. H., Kim, H. K., Jung, G. Y., Jung, Y. J., Lee, K. S., Yun, Y. E., Han, J., Lee, J., Kim, W. S., Choi, J. S., et al. (2020) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2020.1735249 · Cited by 286
Metadata
- Authors
- Manferdini, C., Maumus, M., Gabusi, E., Piacentini, A., Filardo, G., Peyrafitte, J., Jorgensen, C., Bourin, P., Fleury‐Cappellesso, S., Facchini, A., Noël, D., & Lisignoli, G.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2013-04-23
- Volume
- 65
- Issue
- 5
- Pages
- 1271-1281
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W1980174191
- Cited by
- 250
- References
- 6
- FWCI
- 7.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.